http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112961217-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2021-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112961217-B |
| titleOfInvention | A phage polypeptide targeting Siglec-15 |
| abstract | The invention provides a phage polypeptide targeting Siglec-15 and an application thereof, belonging to the field of biotechnology. The present invention obtains a phage polypeptide specifically targeting Siglec-15 through phage display technology, and the phage polypeptide has high affinity and specificity with Siglec-15. The phage polypeptide targeting Siglec-15 according to the present invention can be widely used in various fields of biomedicine, such as biological analysis and detection, tumor imaging, capture and release of memory tumor cells for drug-targeted therapy, etc., and is suitable for clinical screening. Prerequisites are provided in patients for Siglec‑15-targeted therapy. |
| priorityDate | 2021-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 177.